<DOC>
	<DOCNO>NCT01546597</DOCNO>
	<brief_summary>The purpose study evaluate effect steady-state ranolazine steady state PK metformin subject type 2 diabetes mellitus ( T2DM ) .</brief_summary>
	<brief_title>Single Cohort 4-period Study Assess Pharmacokinetics Metformin Alone Combination With Ranolazine</brief_title>
	<detailed_description>The primary objective study follow : • To evaluate effect steady-state ranolazine steady state PK metformin subject T2DM . The secondary objective study follow : - To examine safety tolerability metformin co administer ranolazine steady-state subject T2DM . - To determine steady-state PK ranolazine subject T2DM receive metformin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Males female , 30 65 year old , inclusive Documented history T2DM HbA1c = 6.5 % 10 % , inclusive Fasting serum glucose ≤ 270 mg/dL Screening Fasting Cpeptide ≥ 1 ng/mL Screening Stable metformin monotherapy ( metformin 1000 2000 mg total daily dose least 4 week prior Screening ) Body mass index ( BMI ) = 25 40 kg/m2 , inclusive , Screening Creatinine Clearance &gt; 80 mL/min Screening Females childbearing potential must negative serum pregnancy test Screening negative urine pregnancy test Day 1 must agree use highly effective contraception method Screening throughout duration Treatment Period 14 day follow last dose study drug Type 1 Diabetes Mellitus ( T1DM ) Use insulin therapy &lt; 3 month prior Screening History ketoacidosis , ketosisprone diabetes , lactic acidosis Clinically significant complication diabetes History hypoglycemia Any noninsulin antidiabetic therapy ( metformin ) &lt; 2 month prior Screening Any clinically significant cardiovascular event &lt; 2 month prior Screening Clinically significant , inadequately control , unstable hypertension Hospitalization &lt; 2 month prior Screening major surgery &lt; 3 month prior Screening History gastrointestinal disease surgery could impact drug absorption History substance alcohol substance abuse Positive urine drug screen drug abuse Positive alcohol breath test Any clinically significant exist medical psychiatric condition one require evaluation Treatment select medication Hemoglobin &lt; 12 g/dL male ; &lt; 11 g/dL female Screening Active thyroid disease ( hypo hyperthyroidism ) Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 2.5x upper limit normal QTc interval &gt; 500 msec Screening Females pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Ranolazine</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
</DOC>